These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4828728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
    Bates TR, Rosenberg HA, Tembo AV.
    J Pharm Sci; 1973 Dec; 62(12):2057-8. PubMed ID: 4762187
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug formulation and biologic availability.
    Poole JW.
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract] [Full Text] [Related]

  • 7. Pharmaceutical availability from oral dosage forms: in vitro release of nitrofurantoin from tablets and capsules.
    Senjković R, Kallay N, Vilendecić M.
    Pharmazie; 1987 Mar; 42(3):186-8. PubMed ID: 3602077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man.
    Bron J, Vree TB, Damsma JE, Hekster YA, van der Kleijn E.
    Arzneimittelforschung; 1979 Mar; 29(10):1614-20. PubMed ID: 42416
    [No Abstract] [Full Text] [Related]

  • 10. Proceedings: The comparison of the bioavailabilities of commercial nitrofurantoin tablets.
    McGilveray IJ, Mattok GL, Hossie RD.
    Rev Can Biol; 1973 Mar; 32():Suppl:99-106. PubMed ID: 4777608
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dissolution behavior of commercial tablets extemporaneously converted to capsules.
    Shah PT, Moore WE.
    J Pharm Sci; 1970 Jul; 59(7):1034-6. PubMed ID: 5428077
    [No Abstract] [Full Text] [Related]

  • 13. Preparation of microcapsules from complex coacervation of Gantrez-gelatin. II. In vitro dissolution of nitrofurantoin microcapsules.
    Mortada SA, el Egaky AM, Motawi AM, el Khodery KA.
    J Microencapsul; 1987 Jul; 4(1):23-37. PubMed ID: 3504494
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets.
    Meyer MC, Wood GC, Straughn AB.
    Biopharm Drug Dispos; 1989 Jul; 10(3):321-9. PubMed ID: 2720135
    [Abstract] [Full Text] [Related]

  • 17. Effect of polymers on dissolution from drug suspensions.
    Shah NB, Sheth BB.
    J Pharm Sci; 1976 Nov; 65(11):1618-23. PubMed ID: 11332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A study of the effect of some drugs on the dissolution rate of nitrofurantoin.
    Naggar VF, Shams-Eldeen MA.
    Pharmazie; 1980 Nov; 35(9):550-2. PubMed ID: 7433507
    [Abstract] [Full Text] [Related]

  • 20. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H, Johansen H, Lunde PK, Andersgaard HA, Finholt P, Midtvedt T, Holum E, Martinussen B, Aarnes ED.
    Pharmacology; 1971 Nov; 5(2):108-20. PubMed ID: 5570924
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.